| Jennifer L Wolff, | |
|
2000 John Harden Dr, Jacksonville, AR 72076-2730 | |
| (501) 982-3357 | |
| Not Available |
| Full Name | Jennifer L Wolff |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2000 John Harden Dr, Jacksonville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144821083 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD07711 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer L Wolff, 47 Lindulake Dr, Cabot, AR 72023-9325 Ph: (501) 416-8397 | Jennifer L Wolff, 2000 John Harden Dr, Jacksonville, AR 72076-2730 Ph: (501) 982-3357 |
News Archive
On the heels of Centers for Disease Control announcement earlier today that an ongoing study of the use of Gilead's top selling AIDS treatment, Truvada, as a possible form of pre-exposure prophylaxis for HIV prevention in women is being abruptly halted because the, "…trial could not demonstrate efficacy," the AIDS Healthcare Foundation renewed its call on Gilead Sciences to slow its fast track pursuit of its application for FDA approval of use of its AIDS drug as a possible form of HIV prevention.
Today's health policy headlines report on new White House rules on changes to health insurance benefits, a study regarding employers' medical costs and the likely impact of retirements within the health care workforce.
Elizabeth Groenweghe got a kidney transplant 14 years ago. She now takes several medications to prevent her body from rejecting her transplant organ. But these medications also weaken her immune system, putting her at higher risk of becoming seriously ill if she catches covid-19.
Joseph C. Blader, Ph.D., Assistant Professor, Department of Psychiatry & Behavioral Science at Stony Brook University School of Medicine, and colleagues, found that almost half of children with attention-deficit/hyperactivity disorder whose aggressive behaviors had not been effectively controlled during routine outpatient care could achieve near absence of aggressive, explosive behavior when implementing "first-line" stimulant treatments for ADHD tailored to individual needs, along with behavioral therapy.
A new study reignites the debate regarding the therapeutic utility of convalescent plasma in treating others with the COVID-19.
› Verified 3 days ago
Dr. Adam Lynn Keathley, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 315 S James St, Jacksonville, AR 72076 Phone: 501-982-6979 Fax: 501-241-1220 | |
Courtney Underwood, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2000 John Harden Dr, Jacksonville, AR 72076 Phone: 501-982-3357 Fax: 501-982-5578 | |
Bethany Brooke Dunn, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9913 Jones Rd, Jacksonville, AR 72076 Phone: 501-920-0142 | |
Dr. Amanda Gail Bellamy, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1090 Arnold Dr, Jacksonville, AR 72099 Phone: 501-987-8981 | |
Tristan Phillips, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 103 Gregory Pl, Jacksonville, AR 72076 Phone: 501-985-0822 | |
Roderick Romes Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 103 Gregory Pl, Jacksonville, AR 72076 Phone: 501-985-0822 |